相似文献
1
ACS chemical neuroscience molecule spotlight on Begacestat (GSI-953).
ACS Chem Neurosci. 2012 Jan 18;3(1):3-4. doi: 10.1021/cn200124u.
2
Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
J Pharmacol Exp Ther. 2009 Nov;331(2):598-608. doi: 10.1124/jpet.109.152975. Epub 2009 Aug 11.
3
Discovery of begacestat, a Notch-1-sparing gamma-secretase inhibitor for the treatment of Alzheimer's disease.
J Med Chem. 2008 Dec 11;51(23):7348-51. doi: 10.1021/jm801252w.
4
ACS chemical neuroscience molecule spotlight on BMS-708163.
ACS Chem Neurosci. 2012 Mar 21;3(3):149-50. doi: 10.1021/cn3000179.
5
[Alzheimer's disease treatment by inhibition/modulation of the gamma-secretase activity].
Rinsho Shinkeigaku. 2009 Nov;49(11):845-7. doi: 10.5692/clinicalneurol.49.845.
6
Design, synthesis, and evaluation of tetrahydroquinoline and pyrrolidine sulfonamide carbamates as gamma-secretase inhibitors.
Bioorg Med Chem Lett. 2007 Jun 1;17(11):3010-3. doi: 10.1016/j.bmcl.2007.03.055. Epub 2007 Mar 23.
7
An improved cell-based method for determining the γ-secretase enzyme activity against both Notch and APP substrates.
J Neurosci Methods. 2013 Feb 15;213(1):14-21. doi: 10.1016/j.jneumeth.2012.11.011. Epub 2012 Dec 7.
8
Substituted 4-morpholine N-arylsulfonamides as γ-secretase inhibitors.
Eur J Med Chem. 2016 Nov 29;124:36-48. doi: 10.1016/j.ejmech.2016.08.024. Epub 2016 Aug 13.
9
Synthesis and structure-activity relationship of a novel series of heterocyclic sulfonamide gamma-secretase inhibitors.
Bioorg Med Chem. 2009 Jul 1;17(13):4708-17. doi: 10.1016/j.bmc.2009.04.052. Epub 2009 May 3.
10
In vivo manifestation of Notch related phenotypes in zebrafish treated with Alzheimer's amyloid reducing gamma-secretase inhibitors.
J Neurochem. 2010 Jun;113(5):1200-9. doi: 10.1111/j.1471-4159.2010.06681.x. Epub 2010 Mar 12.
引用本文的文献
1
γ-secretase targeting in Alzheimer's disease.
J Alzheimers Dis Rep. 2025 Jun 23;9:25424823251349529. doi: 10.1177/25424823251349529. eCollection 2025 Jan-Dec.
2
Review on anti-alzheimer drug development: approaches, challenges and perspectives.
RSC Adv. 2024 Apr 5;14(16):11057-11088. doi: 10.1039/d3ra08333k. eCollection 2024 Apr 3.
3
Small-molecule drugs development for Alzheimer's disease.
Front Aging Neurosci. 2022 Nov 1;14:1019412. doi: 10.3389/fnagi.2022.1019412. eCollection 2022.
4
Conformational Models of APP Processing by Gamma Secretase Based on Analysis of Pathogenic Mutations.
Int J Mol Sci. 2021 Dec 18;22(24):13600. doi: 10.3390/ijms222413600.
5
An Overview of Several Inhibitors for Alzheimer's Disease: Characterization and Failure.
Int J Mol Sci. 2021 Oct 6;22(19):10798. doi: 10.3390/ijms221910798.
6
Visible-light mediated carbonyl trifluoromethylative amination as a practical method for the synthesis of β-trifluoromethyl tertiary alkylamines.
Chem Sci. 2020 Oct 9;11(44):12089-12094. doi: 10.1039/d0sc04853d.
7
Computational modeling and biomarker studies of pharmacological treatment of Alzheimer's disease (Review).
Mol Med Rep. 2018 Jul;18(1):639-655. doi: 10.3892/mmr.2018.9044. Epub 2018 May 22.
8
Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms.
J Vis Exp. 2018 Jan 25(131):56795. doi: 10.3791/56795.
9
ACS chemical neuroscience molecule spotlight on BMS-708163.
ACS Chem Neurosci. 2012 Mar 21;3(3):149-50. doi: 10.1021/cn3000179.
本文引用的文献
1
ACS chemical neuroscience molecule spotlight on ELND006: another γ-secretase inhibitor fails in the clinic.
ACS Chem Neurosci. 2011 Jun 15;2(6):279-80. doi: 10.1021/cn2000469.
2
ACS chemical neuroscience molecule spotlight on semagacestat (LY450139).
ACS Chem Neurosci. 2010 Aug 18;1(8):533-4. doi: 10.1021/cn1000606.
3
Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
J Pharmacol Exp Ther. 2009 Nov;331(2):598-608. doi: 10.1124/jpet.109.152975. Epub 2009 Aug 11.
4
(S)-N-(5-Chlorothiophene-2-sulfonyl)-beta,beta-diethylalaninol a Notch-1-sparing gamma-secretase inhibitor.
Bioorg Med Chem Lett. 2009 Feb 1;19(3):926-9. doi: 10.1016/j.bmcl.2008.11.116. Epub 2008 Dec 6.
5
Discovery of begacestat, a Notch-1-sparing gamma-secretase inhibitor for the treatment of Alzheimer's disease.
J Med Chem. 2008 Dec 11;51(23):7348-51. doi: 10.1021/jm801252w.
6
Discovery of a novel series of Notch-sparing gamma-secretase inhibitors.
Bioorg Med Chem Lett. 2008 Jul 15;18(14):4232-6. doi: 10.1016/j.bmcl.2008.05.064. Epub 2008 May 20.
7
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
Science. 2002 Jul 19;297(5580):353-6. doi: 10.1126/science.1072994.
8
The molecular pathology of Alzheimer's disease.
Neuron. 1991 Apr;6(4):487-98. doi: 10.1016/0896-6273(91)90052-2.
9
Alzheimer's disease: the amyloid cascade hypothesis.
Science. 1992 Apr 10;256(5054):184-5. doi: 10.1126/science.1566067.
Zotero 插件